Circulating Inflammatory Proteins and Age-related Macular Degeneration: New Insights from Mendelian Randomization

Yujin Guo1, Jing Zhao1, Zhiqing Chen2

  • 1Department of Ophthalmology, The Second Hospital of Jilin University, Changchun, China.

Abstract

Insights

This study identified specific circulating inflammatory proteins causally linked to age-related macular degeneration (AMD). These findings highlight potential therapeutic targets for AMD pathogenesis.

Area of Science:

  • Ophthalmology
  • Immunology
  • Genetics

Background:

  • Inflammation is a key factor in age-related macular degeneration (AMD).
  • The specific circulating inflammatory proteins implicated in AMD pathogenesis are not fully understood.
  • Identifying these proteins is crucial for understanding AMD development.

Purpose of the Study:

  • To investigate the causal relationships between 91 circulating inflammatory proteins and AMD.
  • To utilize a robust two-sample Mendelian randomization (MR) approach for causal inference.
  • To identify specific inflammatory proteins as potential drivers of AMD.

Main Methods:

  • A two-sample Mendelian randomization (MR) analysis was performed using genome-wide association study (GWAS) data.
  • Five MR methodologies, including inverse variance weighting (IVW), were employed.
  • Sensitivity analyses and validation tests (Steiger's, reverse MR, LDSC) were conducted to ensure result validity and assess pleiotropy.

Main Results:

  • Five inflammatory proteins showed significant associations with overall AMD.
  • Specific proteins were linked to wet AMD (three) and dry AMD (one).
  • Linkage disequilibrium score regression (LDSC) confirmed the causal relationships, with minimal confounding, and protein expression was not affected by AMD genetic prediction.

Conclusions:

  • This research establishes causal links between particular inflammatory proteins and AMD.
  • These identified proteins represent potential therapeutic targets for AMD.
  • The findings contribute to understanding the inflammatory mechanisms driving AMD pathogenesis.